{"id":"https://openalex.org/W2993962813","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","title":"Abstract TMIM-069: PROSPECTIVE CLINICAL VALIDATION OF EX VIVO, PATIENT-SPECIFIC RESPONSE PREDICTION TO FIRST-LINE CHEMOTHERAPY","display_name":"Abstract TMIM-069: PROSPECTIVE CLINICAL VALIDATION OF EX VIVO, PATIENT-SPECIFIC RESPONSE PREDICTION TO FIRST-LINE CHEMOTHERAPY","publication_year":2019,"publication_date":"2019-11-15","ids":{"openalex":"https://openalex.org/W2993962813","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","mag":"2993962813"},"language":"en","primary_location":{"id":"doi:10.1158/1557-3265.ovcasymp18-tmim-069","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5009178613","display_name":"Stephen Shuford","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103605","display_name":"Kiyatec (United States)","ror":"https://ror.org/00we63k03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103605"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Shuford","raw_affiliation_strings":["1KIYATEC, Inc., Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1KIYATEC, Inc., Greenville, SC,","institution_ids":["https://openalex.org/I4210103605"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048151021","display_name":"Jeffrey W. Elder","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283654650","display_name":"Prisma Health","ror":"https://ror.org/03n7vd314","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1283654650"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Elder","raw_affiliation_strings":["2Greenville Health System, Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Greenville Health System, Greenville, SC,","institution_ids":["https://openalex.org/I1283654650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085383208","display_name":"Larry E. Puls","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1283654650","display_name":"Prisma Health","ror":"https://ror.org/03n7vd314","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1283654650"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Puls","raw_affiliation_strings":["2Greenville Health System, Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Greenville Health System, Greenville, SC,","institution_ids":["https://openalex.org/I1283654650"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088406750","display_name":"S. John Weroha","orcid":"https://orcid.org/0000-0002-7130-7259","observed_orcids":["https://orcid.org/0000-0002-7130-7259"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"John Weroha","raw_affiliation_strings":["3Department of Medical Oncology, Mayo Clinic, Rochester, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Mayo Clinic, Rochester, MN,","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112318039","display_name":"Xiaonan Hou","orcid":"https://orcid.org/0000-0002-9406-4747","observed_orcids":["https://orcid.org/0000-0002-9406-4747"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Xiaonan Hou","raw_affiliation_strings":["3Department of Medical Oncology, Mayo Clinic, Rochester, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Mayo Clinic, Rochester, MN,","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048943190","display_name":"Valentina Zanfagnin","orcid":"https://orcid.org/0000-0002-7703-7982","observed_orcids":["https://orcid.org/0000-0002-7703-7982"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Valentina Zanfagnin","raw_affiliation_strings":["3Department of Medical Oncology, Mayo Clinic, Rochester, MN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Department of Medical Oncology, Mayo Clinic, Rochester, MN,","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054033791","display_name":"Alpa Manchandia Nick","orcid":"https://orcid.org/0000-0001-9232-1458","observed_orcids":["https://orcid.org/0000-0001-9232-1458"]},"institutions":[{"id":"https://openalex.org/I1319181961","display_name":"Saint Thomas Health","ror":"https://ror.org/04y40x506","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1319181961","https://openalex.org/I1320343167"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Alpa Nick","raw_affiliation_strings":["4Saint Thomas Health/Ascension, Nashville, TN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Saint Thomas Health/Ascension, Nashville, TN,","institution_ids":["https://openalex.org/I1319181961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049042841","display_name":"Michael P. Stany","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I1319181961","display_name":"Saint Thomas Health","ror":"https://ror.org/04y40x506","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1319181961","https://openalex.org/I1320343167"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael P. Stany","raw_affiliation_strings":["4Saint Thomas Health/Ascension, Nashville, TN,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Saint Thomas Health/Ascension, Nashville, TN,","institution_ids":["https://openalex.org/I1319181961"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5074720434","display_name":"Larry G. Maxwell","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Larry Maxwell","raw_affiliation_strings":["5Inova Health System, Falls Church, VA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Inova Health System, Falls Church, VA,","institution_ids":["https://openalex.org/I116530498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080595928","display_name":"Thomas P. Conrads","orcid":"https://orcid.org/0000-0003-4742-3281","observed_orcids":["https://orcid.org/0000-0003-4742-3281"]},"institutions":[{"id":"https://openalex.org/I116530498","display_name":"Inova Health System","ror":"https://ror.org/04mrb6c22","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I116530498"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Thomas Conrads","raw_affiliation_strings":["5Inova Health System, Falls Church, VA,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5Inova Health System, Falls Church, VA,","institution_ids":["https://openalex.org/I116530498"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111841434","display_name":"C. L. Corless","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Chris Corless","raw_affiliation_strings":["6OHSU Knight Diagnostic Laboratories, Portland, OR,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"6OHSU Knight Diagnostic Laboratories, Portland, OR,","institution_ids":["https://openalex.org/I165690674"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100640276","display_name":"Anil K. Sood","orcid":"https://orcid.org/0000-0002-5415-9901","observed_orcids":["https://orcid.org/0000-0002-5415-9901"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anil K. Sood","raw_affiliation_strings":["7MD Anderson Cancer Center, Houston, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"7MD Anderson Cancer Center, Houston, TX","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5027230506","display_name":"Matthew R. Gevaert","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210103605","display_name":"Kiyatec (United States)","ror":"https://ror.org/00we63k03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103605"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Matthew Gevaert","raw_affiliation_strings":["1KIYATEC, Inc., Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1KIYATEC, Inc., Greenville, SC,","institution_ids":["https://openalex.org/I4210103605"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059055898","display_name":"Howland E. Crosswell","orcid":"https://orcid.org/0000-0002-2165-9889","observed_orcids":["https://orcid.org/0000-0002-2165-9889"]},"institutions":[{"id":"https://openalex.org/I4210103605","display_name":"Kiyatec (United States)","ror":"https://ror.org/00we63k03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103605"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Howland E. Crosswell","raw_affiliation_strings":["1KIYATEC, Inc., Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1KIYATEC, Inc., Greenville, SC,","institution_ids":["https://openalex.org/I4210103605"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5070117566","display_name":"Teresa M. DesRochers","orcid":"https://orcid.org/0000-0003-3819-5491","observed_orcids":["https://orcid.org/0000-0003-3819-5491"]},"institutions":[{"id":"https://openalex.org/I4210103605","display_name":"Kiyatec (United States)","ror":"https://ror.org/00we63k03","country_code":"US","type":"company","lineage":["https://openalex.org/I4210103605"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Teresa M. DesRochers","raw_affiliation_strings":["1KIYATEC, Inc., Greenville, SC,"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1KIYATEC, Inc., Greenville, SC,","institution_ids":["https://openalex.org/I4210103605"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"25","issue":"22_Supplement","first_page":"TMIM","last_page":"069"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10550","display_name":"Ovarian cancer diagnosis and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2743","display_name":"Reproductive Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10769","display_name":"BRCA gene mutations in cancer","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/1311","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T12064","display_name":"Intraperitoneal and Appendiceal Malignancies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ovarian-cancer","display_name":"ovarian cancer","score":0.9959999918937683},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.640999972820282},{"id":"https://openalex.org/keywords/3d-cell-culture","display_name":"3D cell culture","score":0.9129999876022339},{"id":"https://openalex.org/keywords/platinum-based-chemotherapy","display_name":"platinum-based chemotherapy","score":0.5099999904632568},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9190000295639038},{"id":"https://openalex.org/keywords/first-line-chemotherapy-response","display_name":"first-line chemotherapy response","score":0.7549999952316284},{"id":"https://openalex.org/keywords/treatment-response-prediction","display_name":"treatment response prediction","score":0.7369999885559082},{"id":"https://openalex.org/keywords/ca125","display_name":"CA125","score":0.8100000023841858},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.9259999990463257},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.3409999907016754},{"id":"https://openalex.org/keywords/prospective-validation","display_name":"prospective validation","score":0.3540000021457672},{"id":"https://openalex.org/keywords/assay-sensitivity-and-specificity","display_name":"assay sensitivity and specificity","score":0.6169999837875366}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8417669534683228},{"id":"https://openalex.org/C2781100745","wikidata":"https://www.wikidata.org/wiki/Q1977435","display_name":"Debulking","level":4,"score":0.8252054452896118},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.7469461560249329},{"id":"https://openalex.org/C2780427987","wikidata":"https://www.wikidata.org/wiki/Q172341","display_name":"Ovarian cancer","level":3,"score":0.7115446329116821},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.588383138179779},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.583781361579895},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.5684670209884644},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5215356349945068},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5108089447021484},{"id":"https://openalex.org/C188816634","wikidata":"https://www.wikidata.org/wiki/Q2113324","display_name":"Prospective cohort study","level":2,"score":0.48821118474006653},{"id":"https://openalex.org/C2908973413","wikidata":"https://www.wikidata.org/wiki/Q1977435","display_name":"Tumor Debulking","level":3,"score":0.48430219292640686},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.45719659328460693},{"id":"https://openalex.org/C2778336483","wikidata":"https://www.wikidata.org/wiki/Q5090632","display_name":"Chemotherapy regimen","level":3,"score":0.44209590554237366},{"id":"https://openalex.org/C2779399171","wikidata":"https://www.wikidata.org/wiki/Q1483951","display_name":"Malignancy","level":2,"score":0.4255679249763489},{"id":"https://openalex.org/C2781451048","wikidata":"https://www.wikidata.org/wiki/Q415588","display_name":"Carboplatin","level":4,"score":0.4242132902145386},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.42314815521240234}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1557-3265.ovcasymp18-tmim-069","doi":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1557-3265.ovcasymp18-tmim-069","pdf_url":null,"source":{"id":"https://openalex.org/S183149254","display_name":"Clinical Cancer Research","issn_l":"1078-0432","issn":["1078-0432","1557-3265"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":0.98580002784729,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2965335596","https://openalex.org/W2028501811","https://openalex.org/W2092175470","https://openalex.org/W4413843980","https://openalex.org/W41762054","https://openalex.org/W2297979315","https://openalex.org/W2908315866","https://openalex.org/W2241618927","https://openalex.org/W4387824974","https://openalex.org/W2790970832"],"abstract_inverted_index":{"Abstract":[0],"PURPOSE:":[1],"Ovarian":[2,501],"cancer":[3,28,150,183,409,439,443],"remains":[4],"the":[5,11,24,34,71,74,90,102,111,146,160,169,198,215,218,223,247,301,306,311,330,353,427,498],"most":[6,100],"lethal":[7],"gynecological":[8],"malignancy":[9],"in":[10,81,258,270,316,405,437],"United":[12],"States":[13],"even":[14],"though":[15],"there":[16],"are":[17],"a":[18,49,134,173,204,377,415,434],"number":[19],"of":[20,36,48,65,73,83,101,110,148,217,249,260,264,272,276,300,318,323,352,365,382,395,401,418,430,497],"treatment":[21,30,41,51],"options.":[22],"For":[23],"newly":[25,180,406],"diagnosed":[26,181,407],"ovarian":[27,149,182,408,442],"patient,":[29],"is":[31,78,393],"standard":[32,153,161],"with":[33,123,159,179,340,360,376],"majority":[35],"patients":[37,112,151,200,325,410],"receiving":[38],"first-line":[39,250,255,267,402],"platinum/taxol":[40],"following":[42,70,233,246],"surgical":[43,192],"debulking":[44],"or":[45,94,244,346],"as":[46,278,327,414,433],"part":[47],"neo-adjuvant":[50],"regimen.":[52],"Standard":[53],"response":[54,147,219,226,237,257,286,399],"assessment":[55],"to":[56,120,144,152,195,213],"this":[57,130,431],"chemotherapy":[58,157,256,268,366],"combination":[59,403],"depends":[60],"on":[61],"lengthy":[62],"clinical":[63,211,236,261,273,424],"follow-up":[64,212],"at":[66,97,191,335],"least":[67,336],"6":[68,91,242,337,373],"months":[69,92,243,338,348,364,374],"conclusion":[72,248,367],"chemotherapy.":[75,196,251],"This":[76,285,422],"course":[77],"initially":[79],"effective":[80,125],"70-80%":[82],"patients,":[84],"but":[85],"20-30%":[86],"will":[87,105],"relapse":[88,165],"within":[89,230,362],"post-chemotherapy":[93,339,375],"not":[95,116,239],"respond":[96,117],"all.":[98],"Additionally,":[99],"initial":[103],"responders":[104,262,328],"also":[106],"relapse.":[107],"Early":[108],"prediction":[109,287,400],"whose":[113,201],"cancers":[114],"do":[115],"could":[118],"lead":[119],"earlier":[121],"intervention":[122],"more":[124,245,347],"therapy.":[126],"RESULTS:":[127],"To":[128,167],"perform":[129],"prediction,":[131],"we":[132,171],"developed":[133],"test":[135],"utilizing":[136],"live":[137,186],"tumor":[138,187],"tissue":[139,188],"and":[140,155,266,282,368,411,478],"3D":[141,390],"cell":[142],"culture":[143],"predict":[145],"platinum":[154],"taxol":[156],"along":[158],"agents":[162],"used":[163],"for":[164,441],"patients.":[166,444],"validate":[168],"assay,":[170],"performed":[172],"prospective":[174],"trial":[175],"involving":[176],"86":[177],"women":[178],"from":[184],"whom":[185],"was":[189,238,288,303,308],"recovered":[190],"resection":[193],"prior":[194],"Of":[197],"79":[199],"tissues":[202],"yielded":[203],"successful":[205],"assay":[206,302,312,331,355,392,432],"result,":[207],"27":[208],"had":[209],"sufficient":[210],"determine":[214],"accuracy":[216],"predictions":[220,227],"made":[221,229],"by":[222,280,291,329],"assay.":[224],"Assay":[225,252],"were":[228,314,358],"7":[231],"days":[232],"surgery":[234],"while":[235,305],"determined":[240],"until":[241],"results":[253,313],"predicted":[254],"100%":[259],"(19":[263],"19)":[265],"non-response":[269],"62.5%":[271],"non-responders":[274],"(5":[275],"8)":[277],"defined":[279],"CA-125":[281],"radiographic":[283],"surveillance.":[284],"statistically":[289],"significant":[290,428],"Fisher's":[292],"Exact":[293],"test,":[294],"p":[295],"<":[296],"0.001.":[297],"The":[298],"sensitivity":[299],"86%":[304],"specificity":[307],"100%.":[309],"When":[310],"examined":[315],"terms":[317],"progression":[319,333,343,361,379,419],"free":[320,334,344,380,420],"survival,":[321],"19":[322,324],"identified":[326],"remained":[332],"14":[341],"remaining":[342],"10":[345],"post-chemotherapy.":[349],"In":[350],"contrast,":[351],"8":[354],"non-responders,":[356],"3":[357,363],"refractory":[359],"2":[369],"progressed":[370],"less":[371],"than":[372],"mean":[378],"survival":[381],"4.5":[383],"months.":[384],"CONCLUSIONS:":[385],"Our":[386],"rapid,":[387],"ex":[388],"vivo,":[389],"cellular":[391],"capable":[394],"accurate":[396],"patient":[397],"specific":[398],"therapy":[404],"can":[412],"serve":[413],"prognostic":[416],"indicator":[417],"survival.":[421],"preliminary":[423],"validation":[425],"shows":[426],"potential":[429],"future":[435],"tool":[436],"personalized":[438],"care":[440],"Citation":[445],"Format:":[446],"Stephen":[447],"Shuford,":[448],"Jeffrey":[449],"Elder,":[450],"Larry":[451,464],"Puls,":[452],"John":[453],"Weroha,":[454],"Xiaonan":[455],"Hou,":[456],"Valentina":[457],"Zanfagnin,":[458],"Alpa":[459],"Nick,":[460],"Michael":[461],"P.":[462],"Stany,":[463],"Maxwell,":[465],"Thomas":[466],"Conrads,":[467],"Chris":[468],"Corless,":[469],"Anil":[470],"K.":[471],"Sood,":[472],"Matthew":[473],"Gevaert,":[474],"Howland":[475],"E.":[476],"Crosswell,":[477],"Teresa":[479],"M.":[480],"DesRochers.":[481],"PROSPECTIVE":[482],"CLINICAL":[483],"VALIDATION":[484],"OF":[485],"EX":[486],"VIVO,":[487],"PATIENT-SPECIFIC":[488],"RESPONSE":[489],"PREDICTION":[490],"TO":[491],"FIRST-LINE":[492],"CHEMOTHERAPY":[493],"[abstract].":[494],"In:":[495],"Proceedings":[496],"12th":[499],"Biennial":[500],"Cancer":[502,514],"Research":[503],"Symposium;":[504],"Sep":[505],"13-15,":[506],"2018;":[507],"Seattle,":[508],"WA.":[509],"Philadelphia":[510],"(PA):":[511],"AACR;":[512],"Clin":[513],"Res":[515],"2019;25(22":[516],"Suppl):Abstract":[517],"nr":[518],"TMIM-069.":[519]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2019-12-13T00:00:00"}